Top news of the week: 22.09.2021.
Companies And Industries
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in...
Additional data show a booster increases protection 94 percent protection in the U.S. with booster given at two monthsFour-fold increase in antibodies when given at two months 12-fold ...
Clinical Catch-Up: September 13-17
With a conference the size of ESMO, it’s impossible to cover all the exciting news, but here are many of the highlights. Here’s a look.
Novartis veteran Barth takes the helm at autoimmune biotech MiroBio
As MiroBio gears up for its first clinical trial, the autoimmune biotech is getting a new CEO: Carolin Barth, M.D., joins after a 17-year run at Novartis, where she most recently led ...
Speaking at a press conference today, they said the synergistic future oriented deal will help growth of both companies
The strategic alliance between two leading Indian biotech companies, Biocon Biologics Limited and Serum Institute of India (SII), will take India's vaccine and biologics …
BioWorld Insider Podcast
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, ...
Sensorion and Sonova Partner to Research Genetics of Hearing Loss
Swiss audiology tech firm Sonova is partnering French hearing-loss biotech Sensorion to study the genetics of age-related hearing loss in a large, long-term study of newly diagnosed ...
Pfizer says its COVID-19 vaccine is safe and works well for kids ages 5–11
A lower dose of the vaccine produced as many antibodies in elementary school–age kids as a full-dose shot did in teens and young adults.
Q&A: Eli Lilly is making strides in overall trial diversity, but oncology lags behind
Eli Lilly has made strides in increasing the diversity of clinical trials overall, but when you zoom in on oncology, people of color continue to be left out.